SYNTEC OPTICS HOLDINGS, INC.
OPTX · Healthcare · $276.5M mkt cap · FY2025 filings · No moat ·
Doesn't clear the bar
The four filters
Median gross margin 22.6% over 4y, stable.
Median ROIC -3.3%, above the 9% hurdle in 25% of years.
Net debt/EBITDA 1.3x, interest coverage 0x.
Owner earnings -50.7%/yr, share count growing (dilution).
Margin of safety
- Owner earnings (normalized)
- $820053
- Est. intrinsic value / share
- $0.25
- Recent price
- $7.49
- Discount to value
- 2935% above value
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
Fundamentals
There's no normalized fundamentals series for OPTX yet — it appears once ingest has processed its filings.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — OPTX has read No moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#410 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #408BGLC BioNexus Gene Lab Corp.19.7 out of 100, No moatNo moat
- #409SRTA STRATA CRITICAL MEDICAL, INC.19.7 out of 100, No moatNo moat
- #411AHCO AdaptHealth Corp.19.5 out of 100, No moatNo moat
- #412FEIM Frequency Electronics, Inc.19.0 out of 100, No moatNo moat
Compare OPTX with its nearest peers →All Healthcare companies on the Index →
Common questions about OPTX
- Does SYNTEC OPTICS HOLDINGS, INC. have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores SYNTEC OPTICS HOLDINGS, INC. (OPTX) 19.6 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 31, returns on capital 9, balance-sheet safety 38, capital discipline 0.
- Is OPTX stock trading below its intrinsic value?
- Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $0.25 per share versus a recent price of $7.49 — 2935% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
- How has OPTX's Moat Score changed over time?
- The record logs 2 readings since Jul 17, 2026; the latest reads 19.6 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.